There are 1105 resources available
403O - Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT as first-line (1L) treatment for recurrent or metastatic nasopharyngeal cancer (NPC): 3-year follow-up from the RATIONALE-309 study
Presenter: Wen Feng Fang
Session: Proffered Paper session: Head and neck cancers
Resources:
Abstract
Current treatment options for patients with metastatic triple-negative breast cancer (TNBC)
Presenter: Rebecca Dent
Session: Emerging diagnostics and systemic treatments for patients with metastatic breast cancer (mBC)
Resources:
Slides
Webcast
Molecular pathology and clinical management of germinomas in Japan
Presenter: Hirokazu Takami
Session: Intracranial germ cell tumors in East Asia and Europe
Resources:
Slides
Webcast
Optimal treatment duration: When is it safe to stop?
Presenter: Astrid van der Veldt
Session: Optimising immune checkpoint inhibitors (ICI) treatment in advanced melanoma
Resources:
Slides
Webcast
Palliative for adolescents and young adults
Presenter: Eileen Poon
Session: Diversity and inclusion in supportive and palliative care
Resources:
Slides
Webcast
Invited Discussant 128MO and 129MO
Presenter: Sylvie Lorenzen
Session: Mini Oral session: Gastrointestinal tumours
Resources:
Slides
Webcast
Invited Discussant LBA2 and 268O
Presenter: Wei Chong Tan
Session: Proffered Paper session: Genitourinary tumours
Resources:
Slides
Webcast
New treatment paradigms for HR+ / HER2- mBC
Presenter: Evandro de Azambuja
Session: Emerging diagnostics and systemic treatments for patients with metastatic breast cancer (mBC)
Resources:
Slides
Webcast
Treatment of CNS germ cell tumour: Asian perspective
Presenter: Joo-Young Kim
Session: Intracranial germ cell tumors in East Asia and Europe
Resources:
Slides
Webcast
Novel ICI combinations
Presenter: Ana Maria Arance
Session: Optimising immune checkpoint inhibitors (ICI) treatment in advanced melanoma
Resources:
Slides
Webcast